Parameters obtained by fitting blebbistatin observations of Gm at 15 to Eqs. 5 and 6
| Muscle fiber type | Group | Myosin II inhibitor | A1 | τ1 | τ1 (APs) | A2 | τ2 | τ2 (APs) | β | β (APs) |
| (µS/cm2) | (s) | (µS/cm2) | (s) | (s) | ||||||
| EDL | 15 Hz (n = 10) 25 µM dantrolene | BTS | −647 ± 38 | — | 565 ± 67 | 11,178 ± 2,101 | — | 2,566 ± 75 | — | 254 ± 24 |
| EDL | 15 Hz (n = 18) glucose free | BTS | −890 ± 26 | — | 170 ± 9 | 11,056 ± 1,143 | — | 2,127 ± 163 | — | 194 ± 33 |
| Muscle fiber type | Group | Myosin II inhibitor | A1 | τ1 | τ1 (APs) | A2 | τ2 | τ2 (APs) | β | β (APs) |
| (µS/cm2) | (s) | (µS/cm2) | (s) | (s) | ||||||
| EDL | 15 Hz (n = 10) 25 µM dantrolene | BTS | −647 ± 38 | — | 565 ± 67 | 11,178 ± 2,101 | — | 2,566 ± 75 | — | 254 ± 24 |
| EDL | 15 Hz (n = 18) glucose free | BTS | −890 ± 26 | — | 170 ± 9 | 11,056 ± 1,143 | — | 2,127 ± 163 | — | 194 ± 33 |
Experimental observations of Gm in AP-firing EDL fibers with dantrolene or glucose-free conditions. A2, τ2, and β are as in Table II. All data are presented as means ± SEM.